CHARLOTTESVILLE – AMPEL BioSolutions, a leading translational medicine and clinical operations company and ArcheMedX, a digital platform for effective online health care education and training programs, today announced a new collaboration to transform clinical trial recruitment and retention by enabling research sites to more effectively educate and continually engage clinical staff and patients.
Have you ever had trouble enrolling patients for a study? If you answered “yes” then you’re not alone. Most trials end up having to double their original timelines to meet enrollment goals, and 48% of sites under-enroll study volunteers. These delays in drug development cost a lot of money, but
Failed clinical trials come at a huge cost to their pharmaceutical sponsors. Many trial sites fail to enroll more than a single patient—up to 60% of oncology trials, according to Covance, for example. Yet they estimate it costs a sponsor $50,000 for a site start-up, with a loss of almost